Published in Am J Gastroenterol on January 27, 2015
Human norovirus transmission and evolution in a changing world. Nat Rev Microbiol (2016) 1.01
A Cross-Sectional Study of the Prevalence of Gastrointestinal Symptoms and Pathology in Patients With Common Variable Immunodeficiency. Am J Gastroenterol (2016) 0.98
Norovirus vaccines and potential antinorovirus drugs: recent advances and future perspectives. Future Virol (2015) 0.82
Advances Toward a Norovirus Antiviral: From Classical Inhibitors to Lethal Mutagenesis. J Infect Dis (2016) 0.80
Treatment with a Nucleoside Polymerase Inhibitor Reduces Shedding of Murine Norovirus in Stool to Undetectable Levels without Emergence of Drug-Resistant Variants. Antimicrob Agents Chemother (2015) 0.78
T-cell abnormalities in common variable immunodeficiency: the hidden defect. J Clin Pathol (2016) 0.77
Gastrointestinal Disorders Associated with Common Variable Immune Deficiency (CVID) and Chronic Granulomatous Disease (CGD). Curr Gastroenterol Rep (2016) 0.76
Clinical challenges in the management of patients with B cell immunodeficiencies. Clin Exp Immunol (2017) 0.75
Chronic norovirus infection and common variable immunodeficiency. Clin Exp Immunol (2016) 0.75
Improving outcomes of refractory celiac disease - current and emerging treatment strategies. Clin Exp Gastroenterol (2016) 0.75
The Multibiome: The Intestinal Ecosystem's Influence on Immune Homeostasis, Health, and Disease. EBioMedicine (2016) 0.75
Reply to Kempf et al. J Infect Dis (2017) 0.75
Inhibition of calcineurin or IMPDH exerts moderate to potent antiviral activity against norovirus replication. Antimicrob Agents Chemother (2017) 0.75
Recurrent and Sustained Viral Infections in Primary Immunodeficiencies. Front Immunol (2017) 0.75